Coxsackie Cord (Energique, Inc.)


Welcome to the PulseAid listing for the Coxsackie Cord drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Energique, Inc.
NON-PROPRIETARY NAME: Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5
SUBSTANCE NAME: HUMAN COXSACKIEVIRUS A; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-09-23
END MARKETING DATE: 0000-00-00


Coxsackie Cord HUMAN OTC DRUG Details:

Item DescriptionCoxsackie Cord from Energique, Inc.
LABELER NAME: Energique, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6([hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2015-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44911-0250_473c2359-fb49-485a-abd2-f0ea9e830df0
PRODUCT NDC: 44911-0250
APPLICATION NUMBER:

Other HUMAN COXSACKIEVIRUS A; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Energique, Inc.Coxsackie Cord